These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 688278)
1. Interstitial pulmonary fibrosis as a complication of prolonged methyl-CCNU therapy. Lee W; Moore RP; Wampler GL Cancer Treat Rep; 1978 Sep; 62(9):1355-8. PubMed ID: 688278 [No Abstract] [Full Text] [Related]
2. Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU. Block M; Lachowiez RM; Rios C; Hirschl S Med Pediatr Oncol; 1990; 18(3):256-60. PubMed ID: 2329971 [TBL] [Abstract][Full Text] [Related]
3. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration. Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB Oncology; 1977; 34(1):45-6. PubMed ID: 865760 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma. Creagan ET; Ahmann DL; Schutt AJ; Green SJ Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244 [TBL] [Abstract][Full Text] [Related]
5. Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect. Boice JD; Greene MH; Killen JY; Ellenberg SS; Fraumeni JF; Keehn RJ; McFadden E; Chen TT; Stablein D N Engl J Med; 1986 Jan; 314(2):119-20. PubMed ID: 3941685 [No Abstract] [Full Text] [Related]
16. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon. Diggs CH; Wiernik PH; Smyth AC Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200 [No Abstract] [Full Text] [Related]
17. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma. Berd D; Wilson EJ; Bellet RE; Mastrangelo MJ Cancer Res; 1979 Nov; 39(11):4472-6. PubMed ID: 387215 [No Abstract] [Full Text] [Related]
18. Pulmonary fibrosis associated with lomustine (CCNU): a case report. Vats TS; Trueworthy RC; Langston CM Cancer Treat Rep; 1982 Oct; 66(10):1881-2. PubMed ID: 7127329 [No Abstract] [Full Text] [Related]